Stromal Cell CD9 and the Differentiation of Hematopoietic Stem/Progenitor Cells

References

• Kincade P. W., Oritani K., Zheng Z., Borghesi L., Smith-son G., Yamashita Y. Cell interaction molecules utilized in bone marrow. Cell Adhes Commun 1998; 6: 211–215
   PubMed Web of Science ®Google Scholar
• Oritani K., Kincade P. W. Lymphopoiesis and matrix glycoprotein SC1/ECM2. Leuk Lymphoma 1998; 32: 1–7
   PubMed Web of Science ®Google Scholar
• von Kalle C., Glimm H., Schulz G., Mertelsmann R., Henschler R. New developments in hematopoietic stem cell expansion. Curr Opin Hematol 1998; 5: 79–86
   PubMedGoogle Scholar
• Brugger W., Kanz L. Ex vivo expansion of hematopoietic precursor cells. Curr Opin Hematol 1996; 3: 235–240
   PubMedGoogle Scholar
• Spyridonidis A., Mertelsmann R., Henschler R. Hematopoietic cell proliferation and differentiation. Curr Opin Hematol 1996; 3: 321–328
   PubMedGoogle Scholar
• Wright M. D., Tomlinson M. G. The ins and outs of the transmembrane 4 superfamily. Immunot Today 1994; 15: 588–593
   PubMed Web of Science ®Google Scholar
• Maecker H. T., Todd S. C., Levy S. The tetraspan superfamily: molecular facilitators. FASEB J 1997; 11: 428–442
   PubMed Web of Science ®Google Scholar
• Oritani K., Wu X., Medina K., Hudson J., Miyake K., Gimble J. M., Burstein S. A., Kincade P. W. Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood. 1996; 87: 2252–2261
   PubMed Web of Science ®Google Scholar
• Aoyama K., Oritani K., Yokota T., Ishikawa J., Nishiura T., Miyake K., Kanakura Y., Torniyama Y., Kincade P. W., Matsuzawa Y. Stromal cell CD9 regulates differentiation of hematopoietic sterdprogenitor cells. Blood 1999; 93: 2586–2594
   PubMed Web of Science ®Google Scholar
• Radford K. J., Thorne R. F., Hersey P. CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with betal integrins in human melanoma. Biochem Biophys Res Commun 1996; 222: 13–28
   PubMed Web of Science ®Google Scholar
• Berditchevski F., Bazzoni 6., Hemler M. E. Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem 1995; 270: 17784–17790
   PubMed Web of Science ®Google Scholar
• Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Billard M., Conjeaud H., Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 1996; 26: 2657–2665
   PubMed Web of Science ®Google Scholar
• Imai T., Yoshie O. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type I are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J Immunol 1993; 151: 6470–6481
   PubMed Web of Science ®Google Scholar
• Tedder T. F., Zhou L. J., Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 1994; 15: 437–442
   PubMedGoogle Scholar
• Boucheix C., Benoit P., Frachet P., Billard M., Worthington R. E., Gagnon J., Uzan G. Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem 1991; 266: 117–122
   PubMed Web of Science ®Google Scholar
• Atkinson B., Ernst C. S., Christ B. F., Herlyn M., Blaszczyk M., Ross A. H., Herlyn D., Steplewski Z., Koprowski H. Identification of melanoma-associated antigens usinf fixed tissue screening of antibodies. Cancer Res 1984; 44: 2577–2581
   PubMed Web of Science ®Google Scholar
• Ikeyama S., Koyama M., Yamaoka M., Sasada R., Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993; 177: 1231–1237
   PubMed Web of Science ®Google Scholar
• Miyake M., Nakano K., Itoi S. I., Koh T., Taki T. Motility-related protein-1 (MRP-I/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 1996; 56: 1244–1249
   PubMed Web of Science ®Google Scholar
• Oren R., Takahashi S., Doss C., Levy R., Levy S. TAPA-I, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 1990; 10: 4007–4015
   PubMed Web of Science ®Google Scholar
• Todd S. C., Lipps S. G., Crisa L., Salomon D. R., Tsou-kas C. D. CD81 expressed on human thymocytes mediates integrin activation and IL-2-dependent proliferation. J Exp Med 1996; 184: 2055–2060
   PubMed Web of Science ®Google Scholar
• Slupsky J. R., Seehafer J. G., Tang S. -C., Masselis-Smith A., Shaw A. R. E. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein Iib-IIIa complex. J Biol Chem 1989; 264: 12289–12293
   PubMed Web of Science ®Google Scholar
• Higashihara M., Maeda H., Shibata Y., Kume S., Ohashi T. A monoclonal antihuman platelet anti body: a new platelet aggregating substance. Blood 1985; 65: 382–391
   PubMed Web of Science ®Google Scholar
• Miller J. L., Kupinski J. M., Hustad K. O. Characterization of a platelet membrane protein of low molecular weight associated with platelet activation following binding by monoclonal antibody AG-1. Blood 1986; 68: 743–751
   PubMed Web of Science ®Google Scholar
• Anton E. S., Hadjiargyrou M., Patterson P. H., Matthew W. D. CD9 plays a role in Schwann cell migration in vitro. J Neurosci 1995; 15: 584–595
   PubMed Web of Science ®Google Scholar
• Forsyth K. D. Anti-CD9 antibodies augment neutrophil adherence to endothelium. Immunology 1991; 72: 292–296
   PubMed Web of Science ®Google Scholar
• Deng C. T., Terasaki P. I., Iwaki Y., Hofman F. M., Koeffler P., Cahan L., Awar N., Billing R. A monoclonal antibody crossreactive with human platelets, megakaryo-cytes, and common acute lymphocytic leukemic cells. Blood 1983; 61: 759–764
   PubMed Web of Science ®Google Scholar
• Kemshead J. T., Fritschy J., Asser U., Sutherland R., Greaves M. F. Monoclonal antibodies defining markers with apparent selectivity for particular haemopoietic cell types may also detect antigens on cells of neural crest origin. Hybridoma 1982; 1: 109–123
   PubMed Web of Science ®Google Scholar
• Allen T. D., Testa N. G. Cellular interactions in erythroblastic islands in long-term bone marrow cultures, as studied by time-lapse video. Blood Cells 1991; 17: 29–38
   PubMedGoogle Scholar
• Tsai S., Bartelmez S., Stinicka E., Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 1994; 8: 2831–2841
   PubMed Web of Science ®Google Scholar
• Masellis-Smith A., Jensen G. S., Seehafer J. G., Slupsky J. R., Shaw A. R. E. Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J Immunol 1990; 144: 1607–1613
   PubMed Web of Science ®Google Scholar
• Masellis-Smith A., Shaw A. R. CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J Immunol 1994; 152: 2768–2777
   PubMed Web of Science ®Google Scholar
• Brown J. G., Almond B. D., Naglich J. G., Eidels L. Hypersensitivity to diphtheria toxin by mouse cells expressing both diphtheria toxin receptor and CD9 antigen. Proc Natl Acad Sci USA 1993; 90: 8184–8188
   PubMed Web of Science ®Google Scholar
• Iwamoto R., Higashiyama S., Mitamura T., Taniguchi N., Klagsbrun M., Mekada E. Heparin-binding EGF-like growth factor, which acts as diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which upregulates functional receptors and diphtheria toxin sensitivity. EMEO J 1994; 13: 2322–2330
   PubMed Web of Science ®Google Scholar
• Higashiyama S., Iwamoto R., Goishi K., Raab G., Taniguchi N., Klagsbrun M., Mekada E. The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol 1995; 128: 929–938
   PubMed Web of Science ®Google Scholar